ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #7,559Hybrid

Pharmacology Biochemistry and Behavior

Acronym:pbb
•
Abbreviation (ISO):PHARMACOL BIOCHEM BE
•
Identifier (ISSN):0091-3057(Print)/1873-5177(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
2.4↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pharmacology Biochemistry and Behavior

WoS Q2
12452.5420182.7720192.5220203.5320213.720223.620233.320242.520252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q2
0.75
#7,559

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
154

154 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate6.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
112articles/year
17.58% Gold OA•87.6% Original Research

Aims & Scope

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.

Topics Covered (Recognized by AI)
Medicine93.3%Biology93.1%Internal medicine87.7%Psychology83.6%Chemistry79.4%Endocrinology74.8%Biochemistry73.4%Neuroscience66.7%Genetics65.6%Pharmacology59.3%Receptor56.5%Psychiatry53.9%Anesthesia43.8%Dopamine27.3%Antagonist23.5%Organic chemistry23.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BEHAVIORAL SCIENCES

Q2
Rank24/57
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q3
Rank225/330
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank215/356
IndexSCIE
JCISCIE2026

BEHAVIORAL SCIENCES

Q3
Rank30/57
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q3
Rank171/330
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank146/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.4
Articles / Year65
Total Citations9
2025
IF2.5
Articles / Year117
Total Citations200
2024
IF3.3
Articles / Year165
Total Citations819
2023
IF3.6
Articles / Year113
Total Citations708
2022
IF3.697
Articles / Year128
Total Citations1,605

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,559Scopus Q2SCImago Profile
Scopus Coverage:1973-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyNeurosciencePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.75

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.54

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,276 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations979
3-Year Documents354
Citable Documents348

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate54.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ2
Clinical BiochemistryQ2
PharmacologyQ2
ToxicologyQ2
Behavioral NeuroscienceQ3
Biological PsychiatryQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Psychology
Minor Category (Specific Field):
3区BEHAVIORAL SCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmacology Biochemistry and Behavior (acronym: pbb, abbr: PHARMACOL BIOCHEM BE, ISSN: 0091-3057) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in England since 1973. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.750 (Q2), an H-index of 154.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 112 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,276 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1973
Indexing & Databases
SCIEScopusPubMed
Editorial Address
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ca06390b-cef0-4603-894e-ffa7739841fd
Database Updated: 2026-10-16